SUSTAINER: Observational Study of Sinus Rhythm Mapping in Pulmonary Vein Isolation Naive Patients With Atrial Fibrillation

Sponsor
Ziekenhuis Oost-Limburg (Other)
Overall Status
Recruiting
CT.gov ID
NCT06098664
Collaborator
(none)
60
1
5.2
11.6

Study Details

Study Description

Brief Summary

Atrial fibrillation (AF) initially starts in a paroxysmal form, which is mainly based on the presence of triggers. Progression of AF is accompanied by structural and electrical remodelling which can typically be described as a progressive change in electrophysiological properties of the myocardium caused by cardiovascular comorbidities and AF itself. This results in complex electrical conduction disorders, which is defined as electropathology. The aim of our study is to evaluate whether an artificial intelligence (AI)-enabled ECG algorithm (on an ECG in Sinus Rhythm) can predict electropathology in patients with AF who undergo a first PVI.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: AI-enabled ECG score for Atrial Fibrillation (DNN score)
  • Diagnostic Test: Atrial voltage map in sinus rhythm

Study Design

Study Type:
Observational
Anticipated Enrollment :
60 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Observational Study of Sinus Rhythm Mapping in Pulmonary Vein Isolation Naive Patients With Atrial Fibrillation
Actual Study Start Date :
Jun 26, 2023
Anticipated Primary Completion Date :
Nov 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Low score group (DNN-score = 0 - 10%)

The inclusions will be stratified to the deep neural network (DNN) score. The study will enrol 20 patients in each group.

Diagnostic Test: AI-enabled ECG score for Atrial Fibrillation (DNN score)
A 12-lead ECG, performed within 24 hours before the Pulmonary Vein Isolation (PVI) procedure, will be used to calculate the DNN score. (DNN score details: https://doi.org/10.1016/j.jacep.2023.04.008)

Diagnostic Test: Atrial voltage map in sinus rhythm
An atrial voltage map will be constructed prior to the PVI procedure.

Medium score group (DNN-score = 10 - 50%)

The inclusions will be stratified to the deep neural network (DNN) score. The study will enrol 20 patients in each group.

Diagnostic Test: AI-enabled ECG score for Atrial Fibrillation (DNN score)
A 12-lead ECG, performed within 24 hours before the Pulmonary Vein Isolation (PVI) procedure, will be used to calculate the DNN score. (DNN score details: https://doi.org/10.1016/j.jacep.2023.04.008)

Diagnostic Test: Atrial voltage map in sinus rhythm
An atrial voltage map will be constructed prior to the PVI procedure.

High score group (DNN-score = 50 - 100%)

The inclusions will be stratified to the deep neural network (DNN) score. The study will enrol 20 patients in each group.

Diagnostic Test: AI-enabled ECG score for Atrial Fibrillation (DNN score)
A 12-lead ECG, performed within 24 hours before the Pulmonary Vein Isolation (PVI) procedure, will be used to calculate the DNN score. (DNN score details: https://doi.org/10.1016/j.jacep.2023.04.008)

Diagnostic Test: Atrial voltage map in sinus rhythm
An atrial voltage map will be constructed prior to the PVI procedure.

Outcome Measures

Primary Outcome Measures

  1. Low voltage area [During atrial voltage mapping, prior to PVI procedure.]

    Proportion of low voltage area in the left atrium. (Defined as a threshold 0.5mV)

Secondary Outcome Measures

  1. Transition zone voltage area [During atrial voltage mapping, prior to PVI procedure.]

    Proportion of transition zone voltage area in the left atrium. (Defined as a threshold 1mV)

  2. Conduction delay [During atrial voltage mapping, prior to PVI procedure.]

    Number of deceleration zones in the left atrium. (Deceleration zone defined as a zone with a conduction speed of <27cm/s)

  3. Conduction delay score [During atrial voltage mapping, prior to PVI procedure.]

    Weighted score for conduction deceleration zones (taking in account the number of affected zones and the severity of conduction delay)

  4. Conduction time from sinus node to Bachman bundle [During atrial voltage mapping, prior to PVI procedure.]

    Based on Local Activation Time (LAT) sampling. Defined as first point in right atrium to first point in left atrium.

  5. Total LA conduction time [During atrial voltage mapping, prior to PVI procedure.]

    Based on LAT sampling

  6. Left atrial appendage ejection velocity. [Immediately prior to PVI procedure.]

    Measured with TEE pulsed wave doppler.

  7. Left atrial size [Prior to PVI procedure.]

    Measured on CT or MRI imaging

  8. Pericardial adipose tissue volume [Prior to PVI procedure.]

    Measured on CT or MRI imaging

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Provide signed and dated informed consent.

  • First PVI-procedure

  • Age is 18 years or higher.

  • 12-lead ECG available in SR during the last 14 days.

Exclusion Criteria:
  • Mitral insufficiency of grade 3 or 4.

  • Participating in another study that may interfere with participation in this study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ziekenhuis Oost-Limburg Genk Limburg Belgium 3600

Sponsors and Collaborators

  • Ziekenhuis Oost-Limburg

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Laurent Pison, Clinical professor, Ziekenhuis Oost-Limburg
ClinicalTrials.gov Identifier:
NCT06098664
Other Study ID Numbers:
  • Z-2023039
First Posted:
Oct 24, 2023
Last Update Posted:
Oct 24, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Laurent Pison, Clinical professor, Ziekenhuis Oost-Limburg
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 24, 2023